-
公开(公告)号:JPH11137255A
公开(公告)日:1999-05-25
申请号:JP30772197
申请日:1997-11-10
Applicant: AGENCY IND SCIENCE TECHN
Inventor: IMAMURA TORU , ASADA SHINKO , OKA SHUICHI , SUZUKI OSAMU , YONEDA ATSUKO , OTA KEIKO , ODA HIROKO , MIYAGAWA KAZUKO , ORIGASA NORIKO , ASADA TOMOHARU , KOJIMA TETSUTO
IPC: C12N15/09 , A61K31/715 , A61K38/00 , A61K38/17 , A61P9/08 , A61P9/10 , A61P17/00 , A61P17/02 , A61P17/14 , A61P25/00 , A61P25/16 , A61P25/28 , A61P35/00 , A61P43/00 , C07K14/47 , C07K14/50 , C07K19/00 , C12N1/21 , C12N5/00 , C12N5/10 , C12N15/00 , C12P21/02 , C12R1/19 , C12R1/91
Abstract: PROBLEM TO BE SOLVED: To obtain the subject protein excellent in stability such as heat resistance, acid resistance, alkali resistance and resistance to a proteolytic enzyme by allowing a heparin-bondable protein to bind to a sugar chain with a covalent bond. SOLUTION: The subject protein is obtained by allowing a heparin-bondable protein having an amino acid sequence, etc., of the formula to bind to a sugar chain (e.g. a sulfated polysaccharide, a glycosaminoglycan, an N-type sugar chain and an O-type sugar chain) with a covalent bond through a peptide, etc., capable of receiving the addition of the sugar chain. The method for producing the subject protein comprises connecting a cDNA encoding a peptide capable of receiving the addition of any of these sugar chains to the cDNA of the heparin-bondable protein, and allowing the gene product of the connected cDNA to be produced by an animal cell.
-
公开(公告)号:JPH08310966A
公开(公告)日:1996-11-26
申请号:JP11941995
申请日:1995-05-18
Applicant: AGENCY IND SCIENCE TECHN
Inventor: IMAMURA TORU , OKA SHUICHI
Abstract: PURPOSE: To obtain the subject heparin-independent composition having excellent action to proliferate hepatocyte and action to promote the differentiation and survival of neurocyte by using a chimera protein containing partial peptides of both acidic and basic fibroblast growth factor proteins as an active component. CONSTITUTION: A chimera protein containing a partial peptide of an acidic fibroblast growth factor (FGF-1) and a partial peptide of a basic fibroblast growth factor (FGF-2) is used as an active component of the subject pharmaceutical composition. Preferably, the chimera protein is e.g. a protein having the amino acid sequence of formula obtained by recombining the amino acid sequence of FGF-1 with the amino acid sequence of FGF-2. The chimera protein is produced preferably by preparing a cDNA coding for FGF-1 and FGF-2 by cassette format, producing a chimera on the cDNA and expressing the chimera by using an expression system such as E.coli. The amount of the chimera protein in the composition is preferably 0.000001-1wt.%.
-
3.
公开(公告)号:JP2000344796A
公开(公告)日:2000-12-12
申请号:JP2000006643
申请日:2000-01-14
Applicant: AGENCY IND SCIENCE TECHN
Inventor: OKA SHUICHI , YAMAZAKI YUKINAE , IMAMURA TORU , FUJITA YASUKO , YAMAMOTO YUKIORI , OKITA SACHIKO , OZAWA KAZUO , AKAKURA REIKO , ITO CHIKAKO
IPC: C12N15/09 , A61K38/00 , A61K38/22 , A61P17/14 , A61P25/28 , A61P35/00 , A61P43/00 , C07K7/06 , C07K7/08 , C07K14/50 , C12N1/21 , C12P21/02 , C12R1/19
Abstract: PROBLEM TO BE SOLVED: To obtain a new peptide capable of controlling various physiological functions of a specific fibroblast growth factor(FGF) such as hair occurrence or hair growth regulatory effect, nutrition or function regulatory effect of cerebral nerve system, platelet regulatory effect, etc. SOLUTION: This peptide comprises an amino acid sequence of the formula Pro Asp Gly Lys Val Asn Gly Ser His Glu Ala Asn Met or an amino acid sequence obtained by adding an amino acid of the formula Leu or Leu-Ser or Leu-Ser-Gln-Val-His-Arg to the C end of the amino acid sequence and has physiological regulatory activity of FGF-5. The peptide is obtained by an organic chemical synthesis method, a method for hydrolyzing a protein by various methods such as an enzymatic method, etc.
-
公开(公告)号:JP2000143528A
公开(公告)日:2000-05-23
申请号:JP33266699
申请日:1999-11-24
Applicant: AGENCY IND SCIENCE TECHN
Inventor: OKA SHUICHI , INOUE MASAMI , NAKAGOME KAZUYA , TAKAGI SHINOBU , MARUYAMA SUSUMU , TOMIZUKA NOBORU , ITO SHOTA , HATADA KIYOTAKA
IPC: A23L1/30 , A61K8/00 , A61K8/96 , A61K8/97 , A61K36/02 , A61P37/08 , A61P43/00 , A61K35/80 , A61K7/00
Abstract: PROBLEM TO BE SOLVED: To obtain the subject inhibitor having high safety, readily producible, having an inhibiting action on degranulation of mast cell by making the inhibitor include an extract of an alga with water as an active ingredient. SOLUTION: This inhibitor comprises an extract of an alga such as green algae, brown algae, red algae, etc., with water as an active ingredient. The extract, for example, is obtained by removing dirt and organisms attached to the surface of the alga, air-drying and lyophilizing the alga, rewashing the surface of the alga with water, cutting the alga into about 2-5 cm, adding 10-100 mg of the cut alga together with 5-8 ml distilled water into an extracting container, shaking the container for 30 minutes and filtering. The concentration of the active ingredient is 1-100 ppm in the case of a cosmetic and the concentration of the active ingredient is about 0.5 μm to 50 mg/kg weight daily in the administration to a human body. The active ingredient is administered once to several times dividedly.
-
公开(公告)号:JPH115745A
公开(公告)日:1999-01-12
申请号:JP15715397
申请日:1997-06-13
Applicant: AGENCY IND SCIENCE TECHN , OKA SHUICHI , HOKUREN
Inventor: OKA SHUICHI , YAMAZAKI YUKINAE , TOMIZUKA NOBORU , INOUE MASAMI , YAMAMOTO YUKIORI , FUJITA YASUKO , OTAKE TORU , KAWABATA TAKUYA , FUKUMORI YASUNORI
Abstract: PROBLEM TO BE SOLVED: To obtain the subject substance very low in cytotoxicity, safe, highly active and useful for an anti-HIV agent, anti-HIV food, etc., by subjecting plant of perilla order to extraction treatment by using water, purifying the extract through a DEAE anion ion-exchange chromatography and collecting the eluted fractions. SOLUTION: This anti-HIV active substance is obtained by cutting, slitting and powdering the leaves, stems, seeds, etc., of the plants belonging to plant of perilla order, preferably, Prostrate Bugle subfamily, Lavender subfamily, Perilla subfamily and Isodon subfamily of plant of perilla family (e.g. blue chirimen perilla, red chirimen perilla, Prunella Spike, Kassou) subjecting the powdered material to extraction treatment by using water at room temperatures to the boiling temperature, adding a precipitant (e.g. cetyl pyridinium chloride) to the extract to form the precipitate, eluting water-soluble components from the precipitate, purifying the eluted material by a DEAE anion ion-exchange chromatography and collecting the fractions eluted by using e.g. a solution of sodium chloride as an eluting liquid.
-
公开(公告)号:JPH10182454A
公开(公告)日:1998-07-07
申请号:JP1221398
申请日:1998-01-26
Applicant: AGENCY IND SCIENCE TECHN
Inventor: KONO YASUHIRO , HIGASHIHARA TAKANORI , NAKANISHI HIROSHI , NAKAWA YOSHINOBU , OKA SHUICHI , ASADA SHINKO , INOUE MASAMI , NAKAGOME KAZUYA
IPC: C12P17/14 , A01N43/26 , A61K31/39 , A61P31/04 , A61P33/00 , A61P37/08 , C07D327/04 , C12N1/20 , C12R1/01
Abstract: PROBLEM TO BE SOLVED: To obtain an antimicrobial agent for fish diseases having antimicrobial activities against the fish disease and antimicroalgal and antiallergic activities by making the agent include thiogropocin as an active ingredient. SOLUTION: This antimicrobial agent for fish diseases comprises thiotropocin, separated and collected from cultured product prepared by culturing, e.g. a microorganism belonging to the genus Caulobacter (FERM BP-5080) under conditions of a pH within the range of 7.4-7.6, 10-35 deg.C temperature, 5-7 days, aeration spinner culture, etc., as an active ingredient. The method for administering the objective antimicrobial agent for the fish diseases is carried out by including 5-10% thiotorpicin in, e.g. lactose, which is a preparation substrate, providing a powdery or a granular form, mixing the preparation in a daily dose of 0.1-0.5g/kg body weight of the fishes with a blended feed and administering the resultant blended feed to the fishes for 5-7 days.
-
公开(公告)号:JPH0873371A
公开(公告)日:1996-03-19
申请号:JP23403094
申请日:1994-09-02
Applicant: AGENCY IND SCIENCE TECHN , HOKUREN
Inventor: OKA SHUICHI , INOUE MASAMI , NAKAGOME KAZUYA , MARUYAMA SUSUMU , OKADA TOMOKO , KURODA EIKO , OKUNO HIROAKI , TOMIZUKA NOBORU , FUKUMORI YASUNORI
Abstract: PURPOSE: To obtain a suppressant for cancer metastasis or a functional food having high safety to which suppressing actions on cancer metastasis are imparted from a daily ingested food. CONSTITUTION: This suppressant for cancer metastasis is obtained by extracting a beefsteak plant with hot water and thereby providing a hot water extract of the beefsteak plant having suppressing activities against the cancer metastasis. The resultant hot water extract of the beefsteak plant contains further a substance having suppressing activities against the cancer metastasis and 30000-100000 molecular weight therein. The LD50 by oral administration using an ICR strain mouse is >=2g/kg.
-
公开(公告)号:JPH0873365A
公开(公告)日:1996-03-19
申请号:JP23402994
申请日:1994-09-02
Applicant: AGENCY IND SCIENCE TECHN , HOKUREN
Inventor: OKA SHUICHI , INOUE MASAMI , NAKAGOME KAZUYA , MARUYAMA SUSUMU , OKADA TOMOKO , KURODA EIKO , OKUNO HIROAKI , TOMIZUKA NOBORU , FUKUMORI YASUNORI
Abstract: PURPOSE: To provide a blood coagulation inhibiting substance obtainable from an ordinary food, useful for treatment and prophylaxis of thrombosis and having high safety. CONSTITUTION: A beefsteak plant hot-water extract having a fibrin coagulation inhibition activity is obtained by extracting a beefsteak plant with hot water. A blood coagulation inhibiting substance consisting of a polyol and/or a polyphenol of 30,000-100,000 in a molecular weight having fibrin coagulation inhibiting activity is obtained by further treating the beefsteak plant hot-water extract by a purification process. Specifically, a beefsteak plant is extracted with hot water, liquid is separated from solid, the obtained aqueous solution is treated with a precipitant, the water-soluble component is separated, and it is fractionated by column chromatography. The LD50 of the substance in oral administration to an ICR mouse is >=2g/kg.
-
公开(公告)号:JPH0427397A
公开(公告)日:1992-01-30
申请号:JP13472690
申请日:1990-05-24
Applicant: AGENCY IND SCIENCE TECHN
Inventor: OKA SHUICHI , TANAKA HIDEOKI , TOMIZUKA NOBORU , MAEDA HIDEKATSU
IPC: C12P21/00 , C12N5/07 , C12N5/0786 , C12N5/0787 , C12R1/91
Abstract: PURPOSE:To obtain a monokine such as granulocyte macrophage colony stimulation factor useful as a medicine by adding a cell differentiation-inducing substance containing staurosporine to macrophage and culturing the macrophage. CONSTITUTION:Macrophage is cultured by adding a cell differentiation-inducing substance containing staurosporine. The staurosporine can be separated from a filtrate of a culture liquid obtained e.g. by culturing Streptomyces diastato- chromogenes IFO 13389 at pH6-7 and about 30 deg.C for 48hr.
-
公开(公告)号:JPH09208475A
公开(公告)日:1997-08-12
申请号:JP1768696
申请日:1996-02-02
Applicant: KIBUN FOOD CHEMIFA , AGENCY IND SCIENCE TECHN , KIBUN SHOKUHIN KK
Inventor: MURATA KATSUMI , OKA SHUICHI , INOUE MASAMI , NAKAGOME KAZUYA , HONGO SEIJI , ASADA SHINKO , SUGIE MAKIKO , SATO YOKO , TOMIZUKA NOBORU
IPC: A61K31/715 , C08B37/04 , C08L5/00 , C08L5/04
Abstract: PROBLEM TO BE SOLVED: To provide readily producible a new and safe antiallergic agent, an anti-inflammatory agent, a hyaluronidase activity inhibitor and a mast cell degranulation inhibitor. SOLUTION: This invention claims an antiallergic agent containing alginic acid, an alkali metal salt of alginic acid or an alginic acid ester as an active component; an anti-inflammatory agent and a hyaluronidase activity inhibitor containing alginic acid or an alkali metal salt of alginic acid as an active component; and a mast cell degranulation inhibitor containing alginic acid, an alkali metal salt of alginic acid or an alginic acid ester as an active component.
-
-
-
-
-
-
-
-
-